Speaker Details

John Harris, MD, PhD, FAAD

John Harris, MD, PhD, FAAD

SESSIONS

S020 New Innovations in Dermatology: What Devices You Will Be Using in the Next 1-5 Years
Mar 28, 2026 • 9:00 AM - 12:00 PM • Four Seasons 1
S038 Vitiligo
Mar 28, 2026 • 1:00 PM - 4:00 PM • Mile High 2B

DISCLOSURES

AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Aclaris Therapeutics, Inc. – Consultant(Fees); Aldena Therapeutics – Consultant(Fees), Founder(Stock); Almirall – Consultant(Fees); Alys Pharmaceuticals – Founder(Salary), Stockholder Private Company(Fees); Bain Capital – Consultant (1099 relationship)(Fees); Barinthus Biotherapeutics North America, Inc. – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant (1099 relationship)(Fees); Boxer Capital Management, LLC – Consultant (1099 relationship)(Fees); Cour Pharmaceuticals – Investigator(Grants/Research Funding); Dren Bio – Investigator(Grants/Research Funding); Granular Therapeutics – Consultant(Fees); Incyte Corporation – Investigator(Grants/Research Funding); Klirna Biotech, Inc. – Founder(Stock); Klirna Therapeutics – Founder(Stock); Leo Pharma Inc – Investigator(Grants/Research Funding); NexImmune – Investigator(Grants/Research Funding); Nira Biosciences, Inc. – Consultant(Fees), Founder(Stock); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Villaris Therapeutics, Inc – Founder(Stock), Investigator(Grants/Research Funding); Vimela – Consultant(Honoraria), Stockholder(Stock); Vividion Therapeutics – Consultant (1099 relationship)(Fees);